| Followers | 134 |
| Posts | 7040 |
| Boards Moderated | 0 |
| Alias Born | 02/09/2012 |
Friday, October 06, 2017 7:06:30 AM
lets see how smart the market is on the pop. (usually it is reactive, then sobers up)...IMHO...baked into the stock, except for those hearing it for the first time.
anticipated study (and results) will be used by FDA to promote VLN...but timing and extent will be the issue...
Bottom line...BT entering into a licensing agreement with XXII will be the "proof of concept" and the endorsement needed for price traction and holding.
disclosure...sold half in premarket...average $3.50... selling options on the pop.
looking at small holding after today. Likely news will support $3.00 Recent XXII News
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
